Reprint | AASCRM Webinar2026 Lecture 8—Totipotency and Embryonic Origin

Release time:2026/8/19

In order to promote in-depth exchanges on stem cell research in Asia, the Asian Alliance for Stem Cells and Regenerative Medicine (AASCRM) will launch a monthly brand event - the "AASCRM Webinar" series of online academic lectures in 2025, which will continue in 2026.

This series is jointly created by the stem cell societies of China, Japan, South Korea, New Zealand and Australia. Once a month, this series brings together cutting-edge scholars from various countries to share the latest breakthroughs in the field of stem cells and regenerative medicine.

The eighth lecture of the 2026 series of activities was hosted by my country and co-organized by Japan. It will be held online from 11:00am to 12:30am (Beijing time) on August 25, 2026 (Tuesday). We sincerely invite you to gather in the cloud and participate in this academic exchange. This event uses Zoom online conference and is free to attend. You need to register in advance to obtain the participation link.


picture



picture


theme direction

Totipotency and Embryonic Origins


reporting arrangements
Report 1


Title: Capture totipotent stem cells

Reporter: Du Peng

           Beijing University

Report 2


Title: Signaling center-based embryonic model recapitulates early human organogenesis

Reporter: Okae Hiraki

          Kumamoto University


Participation Guide

1. Meeting format: Zoom Online meeting

2. Registration method: The conference is free to attend, but advance registration is required.

o Please click on the link to complete registration:

https://zoom.us/meeting/register/ZLOnhil-TUGXpak4El0xOg#/registration

3. Instructions for participation: The meeting uses the Zoom platform, please be sure to At least two days in advance Sign up for review. After successful registration, the system will send an exclusive conference link to your email (please check your spam email if you do not receive it). Please do not record, copy or share the meeting content privately, and all information must be kept confidential. Violators will be dismissed and legal liability may be pursued. Thanks for your cooperation!